Third Rock Ventures Iii, L.P. Voyager Therapeutics, Inc. (VYGR) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Voyager Therapeutics, Inc.. Currently has a direct ownership of 3.19 Million shares of VYGR, which is worth approximately $17.3 Million. The most recent transaction as insider was on Feb 02, 2023, when has been sold 1,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.19M

0% 3M change

0% 12M change

Total Value Held $17.3 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 02 2023	SELL Other acquisition or disposition	-	1,500,000 Reduced 32.02%	3,185,291 Common Stock
Feb 01 2023	SELL Open market or private sale	$1,198,943 $9.32 p/Share	128,642 Reduced 2.67%	4,685,291 Common Stock
Jan 31 2023	SELL Open market or private sale	$1,711,250 $9.25 p/Share	185,000 Reduced 3.7%	4,813,933 Common Stock
Jan 30 2023	SELL Open market or private sale	$677,250 $9.03 p/Share	75,000 Reduced 1.48%	4,998,933 Common Stock
Jan 27 2023	SELL Open market or private sale	$451,000 $9.02 p/Share	50,000 Reduced 0.98%	5,073,933 Common Stock
Jan 25 2023	SELL Open market or private sale	$461,000 $9.22 p/Share	50,000 Reduced 0.97%	5,123,933 Common Stock
Jan 24 2023	SELL Open market or private sale	$927,000 $9.27 p/Share	100,000 Reduced 1.9%	5,173,933 Common Stock
Jan 23 2023	SELL Open market or private sale	$498,300 $9.06 p/Share	55,000 Reduced 1.03%	5,273,933 Common Stock
Jan 20 2023	SELL Open market or private sale	$915,000 $9.15 p/Share	100,000 Reduced 1.84%	5,328,933 Common Stock
Aug 25 2022	SELL Open market or private sale	$1,244,000 $6.22 p/Share	200,000 Reduced 3.55%	5,428,933 Common Stock
Aug 24 2022	SELL Open market or private sale	$913,330 $6.09 p/Share	149,972 Reduced 2.6%	5,628,933 Common Stock
Aug 16 2022	SELL Open market or private sale	$775,874 $6.04 p/Share	128,456 Reduced 2.17%	5,778,905 Common Stock
Aug 15 2022	SELL Open market or private sale	$820,280 $6.04 p/Share	135,808 Reduced 2.25%	5,907,361 Common Stock
Aug 12 2022	SELL Open market or private sale	$2,129,803 $6.12 p/Share	348,007 Reduced 5.45%	6,043,169 Common Stock
Sep 19 2018	SELL Other acquisition or disposition	-	1,500,000 Reduced 19.01%	6,391,176 Common Stock
Jun 20 2018	SELL Other acquisition or disposition	-	1,500,000 Reduced 15.97%	7,891,176 Common Stock

Also insider at

MYOK

MyoKardia Inc

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV